Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Mar 12;70(10):348-349.
doi: 10.15585/mmwr.mm7010e2.

Travel from the United Kingdom to the United States by a Symptomatic Patient Infected with the SARS-CoV-2 B.1.1.7 Variant - Texas, January 2021

Moriam Ojelade, Annette Rodriguez, Dante Gonzalez, Denzel Otokunrin, Srikanth Ramachandruni, Elizabeth Cuevas, Kelly Moon, Carla Gutiérrez Tyler, Melissa Freeland, Mark Anderson, Kambria Haire, Yuridia Orozco, Fija Scipio, Yuri Springer, Emilie Prot, Jennifer A Shuford

Travel from the United Kingdom to the United States by a Symptomatic Patient Infected with the SARS-CoV-2 B.1.1.7 Variant - Texas, January 2021

Moriam Ojelade et al. MMWR Morb Mortal Wkly Rep. .

Abstract

In December 2020, the B.1.1.7 genetic variant of SARS-CoV-2, the virus that causes COVID-19, was first reported after emergence and rapid circulation in the United Kingdom (1). Evidence suggests that the B.1.1.7 variant is more efficiently transmitted than are other SARS-CoV-2 variants, and widespread circulation could thereby increase SARS-CoV-2 infection and hospitalization rates (1,2). The first reported SARS-CoV-2 B.1.1.7 variant case in the United States was confirmed by sequencing in Colorado on December 29, 2020.* This report describes a person who traveled from the United Kingdom to the United States after experiencing COVID-19-compatible symptoms† and was eventually confirmed to be infected with the B.1.1.7 variant.

PubMed Disclaimer

Conflict of interest statement

All authors have completed and submitted the International Committee of Medical Journal Editors form for disclosure of potential conflicts of interest. No potential conflicts of interest were disclosed.

Similar articles

See all similar articles

Cited by

References

    1. Public Health England. Investigation of novel SARS-CoV-2 variant: variant of concern 202012/01. Technical briefing 3. London, United Kingdom: Public Health England; 2020. https://assets.publishing.service.gov.uk/government/uploads/system/uploa...
    1. Galloway SE, Paul P, MacCannell DR, et al. Emergence of SARS-CoV-2 B.1.1.7 lineage—United States, December 29, 2020–January 12, 2021. MMWR Morb Mortal Wkly Rep 2021;70:95–9. 10.15585/mmwr.mm7003e2 - DOI - PMC - PubMed
    1. CDC, US Department of Health and Human Services. Requirement for negative pre-departure COVID-19 test result for all airline passengers arriving into the United States from the United Kingdom. Fed Regist 2020;85:86933–6. https://www.federalregister.gov/documents/2020/12/31/2020-28981/requirem...
    1. CDC, US Department of Health and Human Services. Requirement for negative pre-departure COVID–19 test result or documentation of recovery from COVID-19 for all airline or other aircraft passengers arriving into the United States from any foreign country. Fed Regist 2021;86:7387–91. https://www.federalregister.gov/documents/2021/01/28/2021-01977/requirem...
    1. Pray IW, Ford L, Cole D, et al.; CDC COVID-19 Surge Laboratory Group. Performance of an antigen-based test for asymptomatic and symptomatic SARS-CoV-2 testing at two university campuses—Wisconsin, September–October 2020. MMWR Morb Mortal Wkly Rep 2021;69:1642–7. 10.15585/mmwr.mm695152a3 - DOI - PMC - PubMed